92 related articles for article (PubMed ID: 20074452)
1. Resorcylic acid lactone L-783,277 inhibits the growth of the human adrenal cancer cell line H295R in vitro.
Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Altmann KH; Hofmann T; Stepien H
Int J Immunopathol Pharmacol; 2009; 22(4):889-95. PubMed ID: 20074452
[TBL] [Abstract][Full Text] [Related]
2. Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro.
Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Kazimierczuk Z; Grieb P; Stepien H
Cell Tissue Res; 2010 May; 340(2):371-9. PubMed ID: 20383646
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells.
van Duursen MB; Nijmeijer SM; Ruchirawat S; van den Berg M
Toxicol Lett; 2010 Feb; 192(3):271-7. PubMed ID: 19913079
[TBL] [Abstract][Full Text] [Related]
4. Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R.
Lichtenauer UD; Shapiro I; Geiger K; Quinkler M; Fassnacht M; Nitschke R; Rückauer KD; Beuschlein F
Endocrinology; 2008 Mar; 149(3):1314-22. PubMed ID: 18063677
[TBL] [Abstract][Full Text] [Related]
5. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 in a preclinical model of adrenocortical carcinoma.
Doghman M; Lalli E
Mol Cell Endocrinol; 2012 Nov; 364(1-2):101-4. PubMed ID: 22960230
[TBL] [Abstract][Full Text] [Related]
7. Resorcylic acid lactones: naturally occurring potent and selective inhibitors of MEK.
Zhao A; Lee SH; Mojena M; Jenkins RG; Patrick DR; Huber HE; Goetz MA; Hensens OD; Zink DL; Vilella D; Dombrowski AW; Lingham RB; Huang L
J Antibiot (Tokyo); 1999 Dec; 52(12):1086-94. PubMed ID: 10695671
[TBL] [Abstract][Full Text] [Related]
8. MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors.
Pereira SS; Monteiro MP; Costa MM; Ferreira J; Alves MG; Oliveira PF; Jarak I; Pignatelli D
J Cell Biochem; 2019 Jan; 120(1):894-906. PubMed ID: 30256438
[TBL] [Abstract][Full Text] [Related]
9. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
Schirmer A; Kennedy J; Murli S; Reid R; Santi DV
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4234-9. PubMed ID: 16537514
[TBL] [Abstract][Full Text] [Related]
10. Metformin as a new anti-cancer drug in adrenocortical carcinoma.
Poli G; Cantini G; Armignacco R; Fucci R; Santi R; Canu L; Nesi G; Mannelli M; Luconi M
Oncotarget; 2016 Aug; 7(31):49636-49648. PubMed ID: 27391065
[TBL] [Abstract][Full Text] [Related]
11. A novel heat shock protein 90 inhibitor potently targets adrenocortical carcinoma tumor suppression.
Wang T; Subramanian C; Blagg BSJ; Cohen MS
Surgery; 2020 Jan; 167(1):233-240. PubMed ID: 31561992
[TBL] [Abstract][Full Text] [Related]
12. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
[TBL] [Abstract][Full Text] [Related]
13. cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells.
Liu J; Li XD; Ora A; Heikkilä P; Vaheri A; Voutilainen R
J Mol Endocrinol; 2004 Oct; 33(2):511-22. PubMed ID: 15525605
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and gene expression profiling of two hydroxylated polybrominated diphenyl ethers in human H295R adrenocortical carcinoma cells.
Song R; Duarte TL; Almeida GM; Farmer PB; Cooke MS; Zhang W; Sheng G; Fu J; Jones GD
Toxicol Lett; 2009 Feb; 185(1):23-31. PubMed ID: 19095052
[TBL] [Abstract][Full Text] [Related]
15. The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells.
De Martino MC; van Koetsveld PM; Feelders RA; Sprij-Mooij D; Waaijers M; Lamberts SW; de Herder WW; Colao A; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2012 Jun; 19(3):351-64. PubMed ID: 22420007
[TBL] [Abstract][Full Text] [Related]
16. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line.
Borges KS; Andrade AF; Silveira VS; Marco Antonio DS; Vasconcelos EJR; Antonini SRR; Tone LG; Scrideli CA
Anticancer Drugs; 2017 Jul; 28(6):634-644. PubMed ID: 28410270
[TBL] [Abstract][Full Text] [Related]
17. The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells.
Pezzani R; Rubin B; Redaelli M; Radu C; Barollo S; Cicala MV; Salvà M; Mian C; Mucignat-Caretta C; Simioni P; Iacobone M; Mantero F
Endocr J; 2014; 61(1):41-53. PubMed ID: 24153038
[TBL] [Abstract][Full Text] [Related]
18. The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.
Pezzani R; Rubin B; Bertazza L; Redaelli M; Barollo S; Monticelli H; Baldini E; Mian C; Mucignat C; Scaroni C; Mantero F; Ulisse S; Iacobone M; Boscaro M
Invest New Drugs; 2016 Oct; 34(5):531-40. PubMed ID: 27177645
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway.
Delhanty PJ; van Koetsveld PM; Gauna C; van de Zande B; Vitale G; Hofland LJ; van der Lely AJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E302-9. PubMed ID: 17405826
[TBL] [Abstract][Full Text] [Related]
20. Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells.
Sanderson T; Renaud M; Scholten D; Nijmeijer S; van den Berg M; Cowell S; Guns E; Nelson C; Mutarapat T; Ruchirawat S
Eur J Pharmacol; 2008 Sep; 593(1-3):92-8. PubMed ID: 18639541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
